Nuñez-Diaz, Cristina
Andersson, Emelie
Schultz, Nina
Pocevičiūtė, Dovilė
Hansson, Oskar
Nilsson, K Peter R.
Wennström, Malin
,
Funding for this research was provided by:
Greta och Johan Kocks stiftelser
Vetenskapsrådet
Hjärnfonden
Ögonfonden
Olle Engkvists Stiftelse
Demensfonden
Åhlens stiftelse
Lund University
Article History
Received: 16 July 2023
Accepted: 24 December 2023
First Online: 2 January 2024
Declarations
:
: Informed consent for using brain and eye tissue, as well as clinical data for research purposes, was obtained from the patients or from their closest relatives, in accordance with the International Declaration of Helsinki and the Code of Conduct for Brain Banking. The tissue collection protocols were approved by the medical ethics committee of VU Amsterdam, and the Swedish Ethical Review Authority approved the study. All data were analyzed anonymously. Animal experiments were carried out in accordance with Swedish animal research regulations, and they were approved by the committee of animal research at Lund University (7482/2017).
: Not applicable.
: M.W. has acquired research support (for the institution) from Eli Lilly. OH has acquired research support (for the institution) from ADx, AVID Radiopharmaceuticals, Biogen, Eli Lilly, Eisai, Fujirebio, GE Healthcare, Pfizer, and Roche. In the past 2 years, he has received consultancy/speaker fees from AC Immune, Amylyx, Alzpath, BioArctic, Biogen, Cerveau, Eisai, Eli Lilly, Fujirebio, Merck, Novartis, Novo Nordisk, Roche, Sanofi and Siemens.